Published in Trends Neurosci on October 24, 2008
Mitochondrial dynamics--fusion, fission, movement, and mitophagy--in neurodegenerative diseases. Hum Mol Genet (2009) 5.15
Mitochondria and the autophagy-inflammation-cell death axis in organismal aging. Science (2011) 3.74
Mitochondria: the next (neurode)generation. Neuron (2011) 3.06
Mutant huntingtin binds the mitochondrial fission GTPase dynamin-related protein-1 and increases its enzymatic activity. Nat Med (2011) 2.87
Calcium signaling and neurodegenerative diseases. Trends Mol Med (2009) 2.03
New insights into the role of mitochondria in aging: mitochondrial dynamics and more. J Cell Sci (2010) 2.03
Mitochondrial dynamics in neurodegeneration. Trends Cell Biol (2012) 1.99
Oxidative stress, mitochondrial dysfunction, and aging. J Signal Transduct (2011) 1.94
Complex II inhibition by 3-NP causes mitochondrial fragmentation and neuronal cell death via an NMDA- and ROS-dependent pathway. Cell Death Differ (2009) 1.66
Mitochondrial loss, dysfunction and altered dynamics in Huntington's disease. Hum Mol Genet (2010) 1.62
Mitochondrial structural and functional dynamics in Huntington's disease. Brain Res Rev (2009) 1.37
Targeting the UPR transcription factor XBP1 protects against Huntington's disease through the regulation of FoxO1 and autophagy. Hum Mol Genet (2012) 1.36
In vivo expression of polyglutamine-expanded huntingtin by mouse striatal astrocytes impairs glutamate transport: a correlation with Huntington's disease subjects. Hum Mol Genet (2010) 1.34
Expression of Huntington's disease protein results in apoptotic neurons in the brains of cloned transgenic pigs. Hum Mol Genet (2010) 1.33
Mitochondrial dysfunction in neurodegenerative diseases. J Pharmacol Exp Ther (2012) 1.33
Redox regulation of mitochondrial fission, protein misfolding, synaptic damage, and neuronal cell death: potential implications for Alzheimer's and Parkinson's diseases. Apoptosis (2010) 1.16
A role of mitochondrial complex II defects in genetic models of Huntington's disease expressing N-terminal fragments of mutant huntingtin. Hum Mol Genet (2013) 1.13
Synaptic mitochondria in synaptic transmission and organization of vesicle pools in health and disease. Front Synaptic Neurosci (2010) 1.12
Shaping the role of mitochondria in the pathogenesis of Huntington's disease. EMBO J (2012) 1.11
The role of mitochondria in neurodegenerative diseases. J Neurol (2011) 1.05
The role of the immune system in Huntington's disease. Clin Dev Immunol (2013) 1.03
Mitochondrial dysfunctions in neurodegenerative diseases: relevance to Alzheimer's disease. Biomed Res Int (2014) 1.01
Coenzyme Q protects Caenorhabditis elegans GABA neurons from calcium-dependent degeneration. Proc Natl Acad Sci U S A (2010) 0.99
Genetics and neuropathology of Huntington's disease. Int Rev Neurobiol (2011) 0.99
Mitochondrial quality control and neurological disease: an emerging connection. Expert Rev Mol Med (2010) 0.98
Mitophagy in neurodegeneration and aging. Front Genet (2012) 0.95
PGC-1α, mitochondrial dysfunction, and Huntington's disease. Free Radic Biol Med (2013) 0.92
Mitochondrial calcium uptake capacity as a therapeutic target in the R6/2 mouse model of Huntington's disease. Hum Mol Genet (2010) 0.92
Impaired mitochondrial trafficking in Huntington's disease. Biochim Biophys Acta (2009) 0.91
Developmental alterations in motor coordination and medium spiny neuron markers in mice lacking pgc-1α. PLoS One (2012) 0.89
Enhanced Ca(2+)-dependent glutamate release from astrocytes of the BACHD Huntington's disease mouse model. Neurobiol Dis (2013) 0.86
Modeling Huntington disease in yeast: perspectives and future directions. Prion (2011) 0.86
Upper gastrointestinal findings in Huntington's disease: patients suffer but do not complain. J Neural Transm (Vienna) (2009) 0.86
Mitochondrion-mediated cell death: dissecting yeast apoptosis for a better understanding of neurodegeneration. Front Oncol (2012) 0.85
S-nitrosylation of dynamin-related protein 1 mediates mutant huntingtin-induced mitochondrial fragmentation and neuronal injury in Huntington's disease. Antioxid Redox Signal (2013) 0.85
Metabolic disturbances in diseases with neurological involvement. Aging Dis (2013) 0.84
Calcium signaling and neurodegeneration. Acta Naturae (2010) 0.83
Amitriptyline improves motor function via enhanced neurotrophin signaling and mitochondrial functions in the murine N171-82Q Huntington disease model. J Biol Chem (2014) 0.83
Mutant Huntingtin induces activation of the Bcl-2/adenovirus E1B 19-kDa interacting protein (BNip3). Cell Death Dis (2010) 0.82
Modeling resilience to schizophrenia in genetically modified mice: a novel approach to drug discovery. Expert Rev Neurother (2012) 0.81
Phosphorylation of mutant huntingtin at serine 116 modulates neuronal toxicity. PLoS One (2014) 0.81
Dithiol-based compounds maintain expression of antioxidant protein peroxiredoxin 1 that counteracts toxicity of mutant huntingtin. J Biol Chem (2012) 0.80
Identification and characterization of unique proline-rich peptides binding to the mitochondrial fission protein hFis1. J Biol Chem (2009) 0.80
Huntingtin protein is essential for mitochondrial metabolism, bioenergetics and structure in murine embryonic stem cells. Dev Biol (2014) 0.80
Altered Ca(2+) signaling in skeletal muscle fibers of the R6/2 mouse, a model of Huntington's disease. J Gen Physiol (2014) 0.80
STIM1 Protein Activates Store-Operated Calcium Channels in Cellular Model of Huntington's Disease. Acta Naturae (2014) 0.79
Human A53T α-synuclein causes reversible deficits in mitochondrial function and dynamics in primary mouse cortical neurons. PLoS One (2013) 0.79
Mitophagy in neurodegeneration and aging. Neurochem Int (2017) 0.78
hMTH1 expression protects mitochondria from Huntington's disease-like impairment. Neurobiol Dis (2012) 0.78
The chicken or the egg: mitochondrial dysfunction as a cause or consequence of toxicity in Huntington's disease. Mech Ageing Dev (2016) 0.77
Increase of angiotensin II type 1 receptor auto-antibodies in Huntington's disease. Mol Neurodegener (2014) 0.77
Do we age because we have mitochondria? Protoplasma (2013) 0.77
Human stefin B normal and patho-physiological role: molecular and cellular aspects of amyloid-type aggregation of certain EPM1 mutants. Front Mol Neurosci (2012) 0.77
The challenge in translating basic research discoveries to treatment of Huntington disease. Rare Dis (2014) 0.77
Identification of Genes Associated with Smad3-dependent Renal Injury by RNA-seq-based Transcriptome Analysis. Sci Rep (2015) 0.76
VCP recruitment to mitochondria causes mitophagy impairment and neurodegeneration in models of Huntington's disease. Nat Commun (2016) 0.76
Neurodegeneration caused by polyglutamine expansion is regulated by P-glycoprotein in Drosophila melanogaster. Genetics (2013) 0.76
Fast-to-Slow Transition of Skeletal Muscle Contractile Function and Corresponding Changes in Myosin Heavy and Light Chain Formation in the R6/2 Mouse Model of Huntington's Disease. PLoS One (2016) 0.75
Enhanced mitochondrial biogenesis ameliorates disease phenotype in a full-length mouse model of Huntington's disease. Hum Mol Genet (2016) 0.75
Early dysfunction and progressive degeneration of the subthalamic nucleus in mouse models of Huntington's disease. Elife (2016) 0.75
The Association of VDAC with Cell Viability of PC12 Model of Huntington's Disease. Front Oncol (2016) 0.75
T1ρ imaging in premanifest Huntington disease reveals changes associated with disease progression. Mov Disord (2015) 0.75
VCP cooperates with UBXD1 to degrade mitochondrial outer membrane protein MCL1 in model of Huntington's disease. Biochim Biophys Acta (2016) 0.75
No evidence of impaired gastric emptying in early Huntington's Disease. PLoS Curr (2011) 0.75
Oxidative Stress in Neurodegenerative Diseases: From Molecular Mechanisms to Clinical Applications. Oxid Med Cell Longev (2017) 0.75
Mitochondria and apoptosis. Science (1998) 23.41
Cell death: critical control points. Cell (2004) 22.56
The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol (2008) 20.89
Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature (2006) 15.69
Metabolic control through the PGC-1 family of transcription coactivators. Cell Metab (2005) 11.66
Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science (1997) 11.53
Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell (2006) 10.18
Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development. J Cell Biol (2003) 10.10
Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator. Endocr Rev (2003) 9.93
The expanding role of mitochondria in apoptosis. Genes Dev (2001) 9.91
Dynamin-related protein Drp1 is required for mitochondrial division in mammalian cells. Mol Biol Cell (2001) 9.67
Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell (1997) 9.57
Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice. Cell (2004) 8.58
Mitochondria: dynamic organelles in disease, aging, and development. Cell (2006) 8.30
Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat Genet (2004) 7.45
Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy. Nat Genet (2000) 7.40
OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28. Nat Genet (2000) 7.20
Functions and dysfunctions of mitochondrial dynamics. Nat Rev Mol Cell Biol (2007) 6.33
PGC-1alpha deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis. PLoS Biol (2005) 5.80
Mitochondrial fusion and fission in mammals. Annu Rev Cell Dev Biol (2006) 5.68
Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules. Cell (2004) 5.67
Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration. Cell (2006) 5.58
The machines that divide and fuse mitochondria. Annu Rev Biochem (2007) 5.56
Regional and progressive thinning of the cortical ribbon in Huntington's disease. Neurology (2002) 5.40
Endophilin is required for synaptic vesicle endocytosis by localizing synaptojanin. Neuron (2003) 5.38
Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease. Science (2001) 5.28
Role of Bax and Bak in mitochondrial morphogenesis. Nature (2006) 5.25
The axonal transport of mitochondria. J Cell Sci (2005) 5.19
Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization. EMBO J (1998) 5.05
Spatial and temporal association of Bax with mitochondrial fission sites, Drp1, and Mfn2 during apoptosis. J Cell Biol (2002) 5.01
Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes. Nat Genet (2003) 4.76
Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease. Science (2002) 4.72
Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin. Cell (2006) 4.53
Mitochondrial fragmentation in neurodegeneration. Nat Rev Neurosci (2008) 4.32
Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines. Nat Neurosci (2002) 4.15
Disruption of axonal transport by loss of huntingtin or expression of pathogenic polyQ proteins in Drosophila. Neuron (2003) 4.04
Dnm1 forms spirals that are structurally tailored to fit mitochondria. J Cell Biol (2005) 3.75
Mitochondrial dysfunction as a cause of optic neuropathies. Prog Retin Eye Res (2004) 3.75
Mitochondria and neuronal survival. Physiol Rev (2000) 3.56
Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1alpha in Huntington's disease neurodegeneration. Cell Metab (2006) 3.38
HEAT repeats in the Huntington's disease protein. Nat Genet (1995) 3.24
Mitofusin 1 and 2 play distinct roles in mitochondrial fusion reactions via GTPase activity. J Cell Sci (2004) 3.20
The hunt for huntingtin function: interaction partners tell many different stories. Trends Biochem Sci (2003) 3.15
Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease. Neuron (2002) 3.15
p53 mediates cellular dysfunction and behavioral abnormalities in Huntington's disease. Neuron (2005) 3.13
Mammalian dynamin-like protein DLP1 tubulates membranes. Mol Biol Cell (2001) 3.08
Decreased expression of striatal signaling genes in a mouse model of Huntington's disease. Hum Mol Genet (2000) 3.07
OGG1 initiates age-dependent CAG trinucleotide expansion in somatic cells. Nature (2007) 3.03
Synaptojanin is recruited by endophilin to promote synaptic vesicle uncoating. Neuron (2003) 2.96
Transcriptional abnormalities in Huntington disease. Trends Genet (2003) 2.91
Huntingtin-protein interactions and the pathogenesis of Huntington's disease. Trends Genet (2004) 2.88
Huntingtin interacting proteins are genetic modifiers of neurodegeneration. PLoS Genet (2007) 2.77
Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitro. Mol Cell Biol (2004) 2.65
Altered axonal mitochondrial transport in the pathogenesis of Charcot-Marie-Tooth disease from mitofusin 2 mutations. J Neurosci (2007) 2.56
Lessons from animal models of Huntington's disease. Trends Genet (2002) 2.54
Huntingtin has a membrane association signal that can modulate huntingtin aggregation, nuclear entry and toxicity. Hum Mol Genet (2007) 2.51
Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release. Hum Mol Genet (2004) 2.31
The human dynamin-related protein OPA1 is anchored to the mitochondrial inner membrane facing the inter-membrane space. FEBS Lett (2002) 2.30
Apoptosome: a platform for the activation of initiator caspases. Cell Death Differ (2006) 2.25
N-methyl-D-aspartate (NMDA) receptor function and excitotoxicity in Huntington's disease. Prog Neurobiol (2006) 2.25
Interaction of Huntington disease protein with transcriptional activator Sp1. Mol Cell Biol (2002) 2.19
Bcl-xL induces Drp1-dependent synapse formation in cultured hippocampal neurons. Proc Natl Acad Sci U S A (2008) 2.17
Huntingtin facilitates dynein/dynactin-mediated vesicle transport. Proc Natl Acad Sci U S A (2007) 2.16
Disturbed Ca2+ signaling and apoptosis of medium spiny neurons in Huntington's disease. Proc Natl Acad Sci U S A (2005) 2.15
Transcriptional dysregulation in Huntington's disease. Trends Neurosci (2000) 2.15
Mitochondrial defect in Huntington's disease caudate nucleus. Ann Neurol (1996) 2.09
Huntingtin phosphorylation acts as a molecular switch for anterograde/retrograde transport in neurons. EMBO J (2008) 2.03
Interaction of Huntingtin-associated protein-1 with kinesin light chain: implications in intracellular trafficking in neurons. J Biol Chem (2005) 1.98
Tissue heterogeneity of the mammalian mitochondrial proteome. Am J Physiol Cell Physiol (2006) 1.97
The first 17 amino acids of Huntingtin modulate its sub-cellular localization, aggregation and effects on calcium homeostasis. Hum Mol Genet (2006) 1.96
Expanded polyglutamine stretches interact with TAFII130, interfering with CREB-dependent transcription. Nat Genet (2000) 1.92
Wild-type huntingtin protects from apoptosis upstream of caspase-3. J Neurosci (2000) 1.92
Cytoplasmic dynein regulates the subcellular distribution of mitochondria by controlling the recruitment of the fission factor dynamin-related protein-1. J Cell Sci (2004) 1.92
Mitochondrial GTPase mitofusin 2 mutation in Charcot-Marie-Tooth neuropathy type 2A. Hum Genet (2004) 1.91
Loss of normal huntingtin function: new developments in Huntington's disease research. Trends Neurosci (2001) 1.84
Weight loss in early stage of Huntington's disease. Neurology (2002) 1.79
Mutant huntingtin aggregates impair mitochondrial movement and trafficking in cortical neurons. Neurobiol Dis (2006) 1.78
Psychiatric and cognitive difficulties as indicators of juvenile huntington disease onset in 29 patients. Arch Neurol (2007) 1.72
Specific progressive cAMP reduction implicates energy deficit in presymptomatic Huntington's disease knock-in mice. Hum Mol Genet (2003) 1.72
Deranged neuronal calcium signaling and Huntington disease. Biochem Biophys Res Commun (2004) 1.72
Molecular cloning and characterization of Bif-1. A novel Src homology 3 domain-containing protein that associates with Bax. J Biol Chem (2001) 1.70
Huntingtin is present in the nucleus, interacts with the transcriptional corepressor C-terminal binding protein, and represses transcription. J Biol Chem (2001) 1.70
Mitochondrial respiration and ATP production are significantly impaired in striatal cells expressing mutant huntingtin. J Biol Chem (2005) 1.67
SH3GLB, a new endophilin-related protein family featuring an SH3 domain. Genomics (2001) 1.64
Huntington's disease: from huntingtin function and dysfunction to therapeutic strategies. Cell Mol Life Sci (2006) 1.57
Excitotoxic injury of the neostriatum: a model for Huntington's disease. Trends Neurosci (1990) 1.51
Involvement of mitochondrial complex II defects in neuronal death produced by N-terminus fragment of mutated huntingtin. Mol Biol Cell (2006) 1.51
Calcium ions in neuronal degeneration. IUBMB Life (2008) 1.47
Cyclin-dependent kinases as a therapeutic target for stroke. Proc Natl Acad Sci U S A (2000) 1.45
Ceramide induces cytochrome c release from isolated mitochondria. Importance of mitochondrial redox state. J Biol Chem (1999) 1.41
Wild-type huntingtin reduces the cellular toxicity of mutant huntingtin in vivo. Am J Hum Genet (2000) 1.38
Mitochondrial impairment in patients and asymptomatic mutation carriers of Huntington's disease. Mov Disord (2005) 1.33
Reduced Apaf-1 levels in cardiomyocytes engage strict regulation of apoptosis by endogenous XIAP. J Cell Biol (2005) 1.28
The predominantly HEAT-like motif structure of huntingtin and its association and coincident nuclear entry with dorsal, an NF-kB/Rel/dorsal family transcription factor. BMC Neurosci (2002) 1.24
Huntingtin associates with acidic phospholipids at the plasma membrane. J Biol Chem (2005) 1.22
Ataxin-2 and huntingtin interact with endophilin-A complexes to function in plastin-associated pathways. Hum Mol Genet (2005) 1.21
Increased susceptibility of striatal mitochondria to calcium-induced permeability transition. J Neurosci (2003) 1.20
Juvenile onset Huntington's disease--clinical and research perspectives. Ment Retard Dev Disabil Res Rev (2001) 1.18
Uncoupling protein 2 protects dopaminergic neurons from acute 1,2,3,6-methyl-phenyl-tetrahydropyridine toxicity. J Neurochem (2005) 1.18
Mutant huntingtin binds the mitochondrial fission GTPase dynamin-related protein-1 and increases its enzymatic activity. Nat Med (2011) 2.87
S-Nitrosylation of DRP1 does not affect enzymatic activity and is not specific to Alzheimer's disease. J Alzheimers Dis (2010) 1.26
The actin-severing protein cofilin is downstream of neuregulin signaling and is essential for Schwann cell myelination. J Neurosci (2012) 0.93